OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - BRISTOL-MYERS SQUIBB | Market Closed - Deutsche Boerse AG 03:41:32 2024-07-12 pm EDT | ||
| 2.28 EUR | +0.44% |
|
| 1 month | +5.07% | ||
| 3 months | +39.02% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 2.28 | +0.44% |
| 24-07-11 | 2.27 | +0.44% |
| 24-07-10 | 2.26 | -0.44% |
| 24-07-09 | 2.27 | -3.81% |
| 24-07-08 | 2.36 | -0.84% |
Delayed Quote Deutsche Boerse AG
Last update July 12, 2024 at 03:41 pm EDT
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SW0QGB |
| ISIN | DE000SW0QGB2 |
| Date issued | 2023-07-27 |
| Strike | 65.52 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.37 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.41 € |
|---|---|
| Lowest since issue | 0.29 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
40.46
USD
Average target price
52.74
USD
Spread / Average Target
+30.35%
- Stock Market
- Certificates
- Certificat
